Credit Suisse’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-51,949
Closed -$133K 3230
2023
Q1
$133K Sell
51,949
-1,914
-4% -$6.07K ﹤0.01% 3178
2022
Q4
$172K Buy
53,863
+5,555
+11% +$20.9K ﹤0.01% 3225
2022
Q3
$168K Buy
48,308
+26
+0.1% +$109 ﹤0.01% 3305
2022
Q2
$177K Buy
48,282
+3,136
+7% +$16K ﹤0.01% 3372
2022
Q1
$300K Buy
45,146
+3,238
+8% +$20K ﹤0.01% 3230
2021
Q4
$293K Sell
41,908
-3,050
-7% -$25.9K ﹤0.01% 4120
2021
Q3
$414K Sell
44,958
-3,258
-7% -$33.4K ﹤0.01% 3926
2021
Q2
$551K Buy
48,216
+894
+2% +$10.2K ﹤0.01% 3784
2021
Q1
$657K Buy
47,322
+13,670
+41% +$158K ﹤0.01% 3587
2020
Q4
$180K Buy
33,652
+13,776
+69% +$70.7K ﹤0.01% 4110
2020
Q3
$83K Sell
19,876
-243
-1% -$1.27K ﹤0.01% 3935
2020
Q2
$126K Buy
20,119
+1,593
+9% +$10.7K ﹤0.01% 3814
2020
Q1
$149K Sell
18,526
-28
-0.2% -$254 ﹤0.01% 3736
2019
Q4
$182K Buy
+18,554
New +$219K ﹤0.01% 4005

Other funds holding OGI

Credit Suisse's OGI Position: Q2 2023 in Review

Credit Suisse sold out of Organigram Holdings (OGI) in Q2 2023, closing a stake of 51,949 shares — an estimated $133K sold.

Credit Suisse first reported a position in OGI in Q4 2019 and held it in 14 quarters. The position peaked at $657K in Q1 2021. 85 funds tracked by Wall St. Rank hold OGI as of Q2 2023.

  • Credit Suisse reported no remaining Organigram Holdings position as of Q2 2023 after selling out during the quarter.
  • Credit Suisse sold 51,949 Organigram Holdings shares in Q2 2023, an estimated $133K.
  • Credit Suisse first reported a position in Organigram Holdings in Q4 2019 and held it in 14 quarters.
  • Credit Suisse's Organigram Holdings position peaked at $657K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.